Abstract
SET and MYND domain-containing protein 1 (SMYD1) has been shown to be responsible for the development of fast twitch and cardiac muscle. Mutations in SMYD1 have been shown to be uniformly fatal in laboratory studies, and not previously described in living humans. We describe here the care of an infant suffering from cardiac failure due to an SMYD1 mutation requiring biventricular assist devices as a bridge to successful heart transplantation. The patient is now doing well 2 years post-transplant and represents a known survivor of a suspected uniformly fatal genetic mutation.
This is a preview of subscription content, log in via an institution to check access.
References
Just S, Meder B, Berger IM et al (2011) The myosin-interacting protein SMYD1 is essential for sarcomere organization. J Cell Sci 124:3127–3136
Du SJ, Tan X, Zhang J (2014) SMYD proteins: key regulators in skeletal and cardiac muscle development and function. Anat Rec (Hoboken) 297:1650–1662
Nagandla H, Lopez S, Yu W et al (2016) Defective myogenesis in the absence of the muscle-specific lysine methyltransferase SMYD1. Dev Biol 410:86–97
Sharma MS, Forbess JM, Guleserian KJ (2012) Ventricular assist device support in children and adolescents with heart failure: the Children's Medical Center of Dallas experience. Artif Organs 36:635–639
Eghtesady P, Almond CS, Tjossem C et al (2013) Post-transplant outcomes of children bridged to transplant with the Berlin Heart EXCOR Pediatric ventricular assist device. Circulation 128:S24–31
Tan X, Rotllant J, Li H, De Deyne P, DeDeyne P, Du SJ (2006) SmyD1, a histone methyltransferase, is required for myofibril organization and muscle contraction in zebrafish embryos. Proc Natl Acad Sci USA 103:2713–2718
Prill K, Windsor Reid P, Wohlgemuth SL, Pilgrim DB (2015) Still heart encodes a structural HMT, SMYD1b, with chaperone-like function during fast muscle sarcomere assembly. PLoS ONE 10:e0142528
Stewart MD, Lopez S, Nagandla H et al (2016) Mouse myofibers lacking the SMYD1 methyltransferase are susceptible to atrophy, internalization of nuclei and myofibrillar disarray. Dis Model Mech 9:347–359
Ye X, Qian Y, Wang Q et al (2016) SMYD1, an SRF-interacting partner is involved in angiogenesis. PLoS ONE 11:e0146468
Töpf A, Griffin HR, Glen E et al (2014) Functionally significant, rare transcription factor variants in tetralogy of Fallot. PLoS ONE 9:e95453
Rasmussen TL, Ma Y, Park CY et al (2015) Smyd1 facilitates heart development by antagonizing oxidative and ER stress responses. PLoS ONE 10:e0121765
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors report no funding and no conflict of interest with this report.
Ethical Approval
This article is a case report and did not require Institutional Review Board approval.
Informed Consent
Informed consent was obtained for all clinical activities described in this case report.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Coyan, G.N., Zinn, M.D., West, S.C. et al. Heart Transplantation from Biventricular Support in Infant with Novel SMYD1 Mutation. Pediatr Cardiol 40, 1745–1747 (2019). https://doi.org/10.1007/s00246-019-02139-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-019-02139-7